Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia
The Journal of Pain, 06/30/09
White LA et al. – Study reports that established fibromyalgia patients use more medical resources and have higher rates of concomitant medication use than newly diagnosed fibromyalgia patients. Findings can help educate providers regarding optimal drug treatment patterns in this population.
Methods- Claims database analysis to describe prescription and medical use in pts with newly diagnosed and established fibromyalgia
- Privately insured pts with 2+ myalgia/myositis claims (1999-2005) were categorized as newly diagnosed or established
- This dichotomy involves comparisons between prediagnosis (S1) and postdiagnosis (S2) stages in the newly diagnosed and between newly diagnosed (S2) and established patients (S3)
- Use of APS guideline medications increased across stages:
- Selective serotonin reuptake inhibitors (SSRIs) (S1, S2, S3: 20.6%, 22.9%, 25.3%)
- Serotonin norepinephrine reuptake inhibitors (SNRIs) (4.5%, 6.4%, 8.9%)
- Pregabalin/gabapentin (5.4%, 7.4%, 8.8%)
- Benzodiazepines (19.0%, 21.1%, 24.2%)
- Non-benzodiazepine sedatives (9.1%, 11.5%, 13.7%), and
- Opioids (39.5%, 43.3%, 43.9%)
- Use of multiple therapeutic classes also increased across stages: 3+ classes (7.1%, 9.6%, 11.8%)
- Office visits to providers increased, on average, after diagnosis:
- Primary care (70.9%, 78.3%, 76.3%)
- Chiropractors (28.8%, 51.1%, 53.3%)
- Rheumatologists (4.2%, 9.9%, 10.5%)
- Mental health (6.4%, 7.3%, 8.3%)
- Average health care costs rose after diagnosis in the newly diagnosed group
Today in Anxiety...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
An algorithm for the pharmacological treatment of depression
Acta Psychiatrica Scandinavica, 11/04/09
How adolescents who cut themselves differ from those who take overdoses
European Child and Adolescent Psychiatry, 10/05/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Does Dual Antidepressant Therapy as Initial Treatment Hasten and Increase Remission from Depression
Journal of Psychiatric Practice, 09/29/09
Today in Other Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Management of agitation and aggression associated with Alzheimers disease: controversies and possible solutions
Current Opinion in Psychiatry, 10/12/09
Sponsor
Article Search
Sponsor


See Latest Articles


